On November 17, 2021. The Signing Ceremony of Partnership Agreement with SATEERA BIONTECH Sdn Bhd for trilateral cooperation framework with IBD researchers was held in Institute of Bioproducts Development (IBD), UTM. The event was officiated by the Assoc. Prof. Ir. Ts. Dr. Roshanida Abd Rahman, Chair, Health & Wellness Research Alliances of Universiti Teknologi Malaysia (UTM), Prof. Dr Hesham Ali El-Enshasy, IBD Director and Dato’ Loh Shin Siong, Executive Director Sateera Biontech Sdn Bhd. Also, presence in the ceremony is the CEO of Sateera Biontech Sdn Bhd, Mr. Skyler Loh Kok Shen and representatives from both organizations. With the awarded of three projects lead by Prof. Dr Hesham Ali-El Enshasy, Dr Nur Izyan Wan Azelee and Dr Nor Hasmaliana Abd Manas, IBD is focusing in developing innovative products for women health and wellness, together with development of prebiotic drinks.
As women’s health has become an urgent priority, and therefore global public-private co-operation and collaboration needs to occur in policy, practice, education, and research. Realizing to these global issues, this signing ceremony also features the launch of “Technological Platform Products for Women in Health Care and Functional Food Product” under Cosmeceutical & Fragrance Unit (IBD) coordinated by Dr Nor Izyan Wan Azelee. This platform is the commitment of IBD and Sateera Biontech Sdn Bhd to promote healthcare and well-being programs for women by enhancing their access to knowledge at local, regional, national, and international levels.
As part of its goal to spearhead R&D&C&I, IBD provide supporting platform for industries to have industrial research with the institute and licensing its own product and technology for the benefits of research to society. IBD is most known as world-class industrial research institute with more than 100 indexed publications along with more than 20 actives international MoUs and more 15 awarded contracts research every year.
